Cargando…
Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications
Over the past decade, ROS-sensitive formulations have been widely used in atherosclerosis applications such as ROS scavenging, drug delivery, gene delivery, and imaging. The intensified interest in ROS-sensitive formulations is attributed to their unique self-adaptive properties, involving the main...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468237/ https://www.ncbi.nlm.nih.gov/pubmed/34575528 http://dx.doi.org/10.3390/pharmaceutics13091452 |
_version_ | 1784573613474578432 |
---|---|
author | Ji, Hao Peng, Renyi Jin, Libo Ma, Jiahui Yang, Qinsi Sun, Da Wu, Wei |
author_facet | Ji, Hao Peng, Renyi Jin, Libo Ma, Jiahui Yang, Qinsi Sun, Da Wu, Wei |
author_sort | Ji, Hao |
collection | PubMed |
description | Over the past decade, ROS-sensitive formulations have been widely used in atherosclerosis applications such as ROS scavenging, drug delivery, gene delivery, and imaging. The intensified interest in ROS-sensitive formulations is attributed to their unique self-adaptive properties, involving the main molecular mechanisms of solubility switch and degradation under the pathological ROS differences in atherosclerosis. This review outlines the advances in the use of ROS-sensitive formulations in atherosclerosis applications during the past decade, especially highlighting the general design requirements in relation to biomedical functional performance. |
format | Online Article Text |
id | pubmed-8468237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84682372021-09-27 Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications Ji, Hao Peng, Renyi Jin, Libo Ma, Jiahui Yang, Qinsi Sun, Da Wu, Wei Pharmaceutics Review Over the past decade, ROS-sensitive formulations have been widely used in atherosclerosis applications such as ROS scavenging, drug delivery, gene delivery, and imaging. The intensified interest in ROS-sensitive formulations is attributed to their unique self-adaptive properties, involving the main molecular mechanisms of solubility switch and degradation under the pathological ROS differences in atherosclerosis. This review outlines the advances in the use of ROS-sensitive formulations in atherosclerosis applications during the past decade, especially highlighting the general design requirements in relation to biomedical functional performance. MDPI 2021-09-11 /pmc/articles/PMC8468237/ /pubmed/34575528 http://dx.doi.org/10.3390/pharmaceutics13091452 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ji, Hao Peng, Renyi Jin, Libo Ma, Jiahui Yang, Qinsi Sun, Da Wu, Wei Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications |
title | Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications |
title_full | Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications |
title_fullStr | Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications |
title_full_unstemmed | Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications |
title_short | Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications |
title_sort | recent advances in ros-sensitive nano-formulations for atherosclerosis applications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468237/ https://www.ncbi.nlm.nih.gov/pubmed/34575528 http://dx.doi.org/10.3390/pharmaceutics13091452 |
work_keys_str_mv | AT jihao recentadvancesinrossensitivenanoformulationsforatherosclerosisapplications AT pengrenyi recentadvancesinrossensitivenanoformulationsforatherosclerosisapplications AT jinlibo recentadvancesinrossensitivenanoformulationsforatherosclerosisapplications AT majiahui recentadvancesinrossensitivenanoformulationsforatherosclerosisapplications AT yangqinsi recentadvancesinrossensitivenanoformulationsforatherosclerosisapplications AT sunda recentadvancesinrossensitivenanoformulationsforatherosclerosisapplications AT wuwei recentadvancesinrossensitivenanoformulationsforatherosclerosisapplications |